Patent · US Active

KRas inhibitors

US12351591B2 · kind B2 · utility

0Cited by

0References

33Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

David Anthony Barda · Indianapolis, US
Jolie Anne Bastian · Indianapolis, US
Kelly Wayne Furness · Avon, US
Deqi Guo · Edmonton, CA
James Robert Henry · Indianapolis, US
Richard Duane Johnston · Greenfield, US
Jason Eric Lamar · Indianapolis, US
Tao Liu · Shanghai, CN
Michael Rodriguez · Arlington Heights, US
Almudena Rubio · Carmel, US
Chong SI · Brookline, US
Gaiying Zhao · Carmel, US
Mohammad Sadegh Zia-Ebrahimi · Indianapolis, US
Matthew Patrick BAUMGARTNER · Aldan, US
Isabel Rojo · Madrid, ES
Mario BARBERIS · Madrid, ES
Santiago CARBALLARES MARTIN · Madrid, ES
Pablo GARCIA LOSADA · Madrid, ES
Sonia Maria GUTIERREZ SANFELICIANO · Madrid, ES
Wenceslao Lumeras Amador · Madrid, ES
Victoriano MOLERO FLÓREZ · Madrid, ES
Maria Lourdes PRIETO VALLEJO · Madrid, ES

Key dates

Filing date	Mar 24, 2023
Grant date	Jul 8, 2025
Priority date	—
Expiry date	Mar 24, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides compounds of the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.